Log in to save to my catalogue

Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting in...

Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1846414518

Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme

About this item

Full title

Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme

Publisher

Canada: NRC Research Press

Journal title

Biochemistry and cell biology, 2016-12, Vol.94 (6), p.534-542

Language

English

Formats

Publication information

Publisher

Canada: NRC Research Press

More information

Scope and Contents

Contents

Omega-3 polyunsaturated fatty acids (PUFAs) have been proposed to be highly beneficial in Alzheimer’s disease (AD). AD pathology is closely linked to an overproduction and accumulation of amyloid-β (Aβ) peptides as extracellular senile plaques in the brain. Total Aβ levels are not only dependent on its production by proteolytic processing of the am...

Alternative Titles

Full title

Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1846414518

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1846414518

Other Identifiers

ISSN

0829-8211

E-ISSN

1208-6002

DOI

10.1139/bcb-2015-0149

How to access this item